Ozempic is the brand name for semaglutide manufactured by Novo Nordisk, FDA-approved for type 2 diabetes (2017).

How is Ozempic different from Wegovy?

Same active ingredient (semaglutide). Ozempic is labeled for T2D (max 2.0 mg); Wegovy is labeled for chronic weight management and CV risk reduction (max 2.4 mg).

Ozempic — Drug Reference, Dosing, Trials

Ozempic

Brand name for semaglutide, FDA-approved for type 2 diabetes mellitus. Same active ingredient as Wegovy and Rybelsus.

By Novo NordiskUpdated 2026-05-08

Editorial team

Dr. Sam Saberian · Lead Medical Researcher

Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Ozempic overview

Brand name for semaglutide, FDA-approved for type 2 diabetes mellitus. Same active ingredient as Wegovy and Rybelsus.

Ozempic at a glance

Manufacturer

Novo Nordisk

FDA status

FDA-approved

Clinical research overview
Compare GLP-1 forms
Compounded vs brand
NexLife (Editor's #1)

Ozempic

Ozempic overview

Ozempic at a glance

Related pages